Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL9777799 | 0.95 | CA4 (0.55) | — | |
| Bicarbonate SCHEMBL681049 | 0.95 | CA4 (0.55) | — | |
| Bicarbonate SCHEMBL5173075 | 0.95 | CA4 (0.55) | — | |
| Bicarbonate SCHEMBL1716282 | 0.95 | — | — | |
| Bicarbonate SCHEMBL8712057 | 0.95 | — | — | |
| Bicarbonate SCHEMBL14562574 | 0.90 | — | — | |
| Bicarbonate SCHEMBL1318468 | 0.90 | — | — | |
| Bicarbonate SCHEMBL23849739 | 0.89 | CA4 (0.60) | — | |
| Bicarbonate SCHEMBL3899 | 0.89 | — | — | |
| Bicarbonate SCHEMBL3395193 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0723777-B1 | TABLET CONTAINING ENTERIC GRANULES | MITSUBISHI PHARMA CORP (JP) | 2002-07-03 | — | — | EP | claimed |
| US-5798120-A | CONTAINING 5-METHOXY-2-(((4-METHOXY-3,5-DIMETHYL-2-PYRIDYL) METHYL)SULFINYL)IMIDAZO(4,5-B)PYRIDINE AS AN ACTIVE AGENT AND ALUMINUM INORGANIC AND ORGANIC COMPOUNDS; ACID RESISTANCE | TOKYO TANABE COMPANY LIMITED (JP) | 1998-08-25 | — | — | US | claimed |
| EP-0723777-A1 | TABLET CONTAINING ENTERIC GRANULES | TOKYO TANABE COMPANY LIMITED (JP) | 1996-07-31 | — | — | EP | claimed |
| EP-2865369-B1 | Solid dispersions of isoxazoline compounds | SUMITOMO CHEMICAL CO (JP) | 2023-05-24 | — | — | EP | disclosed |
| US-20230059899-A1 | CELLULOSE COMPOSITION, TABLET, AND ORALLY DISINTEGRATING TABLET | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-02-23 | — | — | US | disclosed |
| US-20220062182-A1 | CELLULOSE POWDER, USE THEREOF, AND TABLETS | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2022-03-03 | — | — | US | disclosed |
| EP-3904429-A1 | CELLULOSE POWDER, USE THEREOF, AND TABLET | Asahi Kasei Kabushiki Kaisha (JP) | 2021-11-03 | — | — | EP | disclosed |
| EP-1712583-B1 | POROUS CELLULOSE AGGREGATE AND FORMED PRODUCT COMPOSITION COMPRISING THE SAME | ASAHI CHEMICAL IND (JP) | 2020-09-16 | — | — | EP | disclosed |
| WO-2020136995-A1 | CELLULOSE POWDER, USE THEREOF, AND TABLET | 旭化成株式会社 | 2020-07-02 | — | — | WO | disclosed |
| US-9446137-B2 | Composite particles which contain both cellulose and inorganic compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-09-20 | — | — | US | disclosed |
| US-9371293-B2 | Isoxazoline compound composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-06-21 | — | — | US | disclosed |
| EP-2042164-A1 | STABILIZED SOLID PREPARATION | Takeda Pharmaceutical Company Limited (JP) | 2009-04-01 | — | — | EP | disclosed |
| US-20070190017-A1 | Porous cellulose aggregate and formed product composition comprising the same | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1712583-A1 | POROUS CELLULOSE AGGREGATE AND FORMED PRODUCT COMPOSITION COMPRISING THE SAME | Asahi Kasei Chemicals Corporation (JP) | 2006-10-18 | — | — | EP | disclosed |
| US-20030153623-A1 | Solid preparation containing sparingly soluble NSAIDs | YAMANOUCHI PHARMACEUTICAL CO., LTD. | 2003-08-14 | — | — | US | disclosed |
| EP-0723777-B1 | TABLET CONTAINING ENTERIC GRANULES | MITSUBISHI PHARMA CORP (JP) | 2002-07-03 | — | — | EP | disclosed |
| EP-1103258-A1 | SOLID PREPARATION CONTAINING SPARINGLY SOLUBLE NSAIDS | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 2001-05-30 | — | — | EP | disclosed |
| US-5798120-A | CONTAINING 5-METHOXY-2-(((4-METHOXY-3,5-DIMETHYL-2-PYRIDYL) METHYL)SULFINYL)IMIDAZO(4,5-B)PYRIDINE AS AN ACTIVE AGENT AND ALUMINUM INORGANIC AND ORGANIC COMPOUNDS; ACID RESISTANCE | TOKYO TANABE COMPANY LIMITED (JP) | 1998-08-25 | — | — | US | disclosed |
| US-5798120-A | CONTAINING 5-METHOXY-2-(((4-METHOXY-3,5-DIMETHYL-2-PYRIDYL) METHYL)SULFINYL)IMIDAZO(4,5-B)PYRIDINE AS AN ACTIVE AGENT AND ALUMINUM INORGANIC AND ORGANIC COMPOUNDS; ACID RESISTANCE | TOKYO TANABE COMPANY LIMITED (JP) | 1998-08-25 | — | — | US | disclosed |
| EP-0723777-A1 | TABLET CONTAINING ENTERIC GRANULES | TOKYO TANABE COMPANY LIMITED (JP) | 1996-07-31 | — | — | EP | disclosed |